David Toung
Stock Analyst at Argus Research
(4.27)
# 500
Out of 4,479 analysts
83
Total ratings
64.63%
Success rate
9.32%
Average return
Main Sectors:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $201.48 | - | 3 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $310.77 | +9.41% | 7 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $584.83 | +14.56% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $106.27 | +41.15% | 3 | May 21, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $120 → $115 | $96.54 | +19.12% | 5 | May 15, 2024 | |
| LLY Eli Lilly | Maintains: Buy | $770 → $840 | $906.71 | -7.36% | 3 | May 14, 2024 | |
| HOLX Hologic | Maintains: Buy | $89 → $95 | $73.53 | +29.20% | 1 | May 9, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $80 → $110 | $76.33 | +44.11% | 1 | Apr 1, 2024 | |
| LH Labcorp Holdings | Upgrades: Buy | n/a | $202.73 | - | 1 | Mar 25, 2024 | |
| PFE Pfizer | Downgrades: Hold | n/a | $27.83 | - | 1 | Mar 22, 2024 | |
| HUM Humana | Downgrades: Hold | n/a | $374.82 | - | 5 | Mar 13, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $540 → $550 | $533.93 | +3.01% | 5 | Nov 6, 2023 | |
| CTLT Catalent | Upgrades: Buy | $62 | $56.20 | +10.32% | 2 | Sep 5, 2023 | |
| IART Integra LifeSciences Holdings | Downgrades: Hold | n/a | $29.19 | - | 1 | Jun 8, 2023 | |
| SYK Stryker | Maintains: Buy | $285 → $310 | $334.30 | -7.27% | 2 | May 25, 2023 | |
| SILK Silk Road Medical | Maintains: Buy | $70 → $55 | $27.02 | +103.55% | 3 | May 22, 2023 | |
| HCA HCA Healthcare | Maintains: Buy | $285 → $310 | $319.70 | -3.03% | 2 | May 10, 2023 | |
| ISRG Intuitive Surgical | Maintains: Buy | $265 → $320 | $438.81 | -27.08% | 3 | Dec 22, 2022 | |
| ABT Abbott Laboratories | Maintains: Buy | $150 → $135 | $103.20 | +30.81% | 3 | Jul 28, 2022 | |
| UNH UnitedHealth Group | Maintains: Buy | $580 → $650 | $498.24 | +30.46% | 4 | Jul 25, 2022 | |
| GILD Gilead Sciences | Upgrades: Buy | $75 | $68.40 | +9.65% | 3 | Jan 28, 2022 | |
| BMY Bristol-Myers Squibb Company | Downgrades: Hold | n/a | $40.45 | - | 1 | Nov 1, 2021 | |
| MRK Merck & Co. | Upgrades: Buy | n/a | $127.72 | - | 3 | Nov 1, 2021 | |
| MDT Medtronic | Maintains: Buy | n/a | $77.37 | - | 4 | Aug 27, 2021 | |
| TDOC Teladoc Health | Downgrades: Hold | n/a | $9.40 | - | 1 | Aug 2, 2021 | |
| TECH Bio-Techne | Maintains: Buy | n/a | $71.24 | - | 2 | Jun 18, 2021 | |
| AZN AstraZeneca | Downgrades: Hold | n/a | $76.99 | - | 1 | Apr 12, 2021 | |
| NVS Novartis AG | Downgrades: Hold | n/a | $106.44 | - | 1 | Mar 10, 2021 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $165.96 | - | 4 | Jun 2, 2020 | |
| JNJ Johnson & Johnson | Reiterates: Buy | n/a | $146.03 | - | 2 | Mar 27, 2020 |
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $201.48
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $310.77
Upside: +9.41%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $584.83
Upside: +14.56%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $106.27
Upside: +41.15%
Cardinal Health
May 15, 2024
Maintains: Buy
Price Target: $120 → $115
Current: $96.54
Upside: +19.12%
Eli Lilly
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $906.71
Upside: -7.36%
Hologic
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $73.53
Upside: +29.20%
GE HealthCare Technologies
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $76.33
Upside: +44.11%
Labcorp Holdings
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $202.73
Upside: -
Pfizer
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $27.83
Upside: -
Humana
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $374.82
Upside: -
Thermo Fisher
Nov 6, 2023
Maintains: Buy
Price Target: $540 → $550
Current: $533.93
Upside: +3.01%
Catalent
Sep 5, 2023
Upgrades: Buy
Price Target: $62
Current: $56.20
Upside: +10.32%
Integra LifeSciences Holdings
Jun 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $29.19
Upside: -
Stryker
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $334.30
Upside: -7.27%
Silk Road Medical
May 22, 2023
Maintains: Buy
Price Target: $70 → $55
Current: $27.02
Upside: +103.55%
HCA Healthcare
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $319.70
Upside: -3.03%
Intuitive Surgical
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $438.81
Upside: -27.08%
Abbott Laboratories
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $103.20
Upside: +30.81%
UnitedHealth Group
Jul 25, 2022
Maintains: Buy
Price Target: $580 → $650
Current: $498.24
Upside: +30.46%
Gilead Sciences
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $68.40
Upside: +9.65%
Bristol-Myers Squibb Company
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $40.45
Upside: -
Merck & Co.
Nov 1, 2021
Upgrades: Buy
Price Target: n/a
Current: $127.72
Upside: -
Medtronic
Aug 27, 2021
Maintains: Buy
Price Target: n/a
Current: $77.37
Upside: -
Teladoc Health
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $9.40
Upside: -
Bio-Techne
Jun 18, 2021
Maintains: Buy
Price Target: n/a
Current: $71.24
Upside: -
AstraZeneca
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $76.99
Upside: -
Novartis AG
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $106.44
Upside: -
AbbVie
Jun 2, 2020
Upgrades: Buy
Price Target: n/a
Current: $165.96
Upside: -
Johnson & Johnson
Mar 27, 2020
Reiterates: Buy
Price Target: n/a
Current: $146.03
Upside: -